Researchers at Lancaster University have been awarded £396,000 by the Medical Research Council to explore the possibility that the protein alpha-synuclein, which accumulates in parts of the brain affected by Parkinson's disease, can be detected in the blood and act as a marker for the disease.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber? Login